Annual SGA
$28.28 M
-$1.02 M-3.47%
December 31, 2023
Summary
- As of February 12, 2025, SYRS annual SGA is $28.28 million, with the most recent change of -$1.02 million (-3.47%) on December 31, 2023.
- During the last 3 years, SYRS annual SGA has risen by +$6.96 million (+32.62%).
- SYRS annual SGA is now -3.47% below its all-time high of $29.30 million, reached on December 31, 2022.
Performance
SYRS SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$5.66 M
+$192.00 K+3.51%
September 30, 2024
Summary
- As of February 12, 2025, SYRS quarterly SGA is $5.66 million, with the most recent change of +$192.00 thousand (+3.51%) on September 30, 2024.
- Over the past year, SYRS quarterly SGA has dropped by -$2.11 million (-27.16%).
- SYRS quarterly SGA is now -29.98% below its all-time high of $8.08 million, reached on September 30, 2022.
Performance
SYRS Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.96 B
-$97.81 M-3.42%
September 30, 2024
Summary
- As of February 12, 2025, SYRS TTM SGA is -$2.96 billion, with the most recent change of -$97.81 million (-3.42%) on September 30, 2024.
- Over the past year, SYRS TTM SGA has dropped by -$2.99 billion (-10043.15%).
- SYRS TTM SGA is now -5422.77% below its all-time high of -$53.51 million.
Performance
SYRS TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
SYRS Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.5% | -27.2% | -10000.0% |
| 3 y3 years | +32.6% | -23.6% | -10000.0% |
| 5 y5 years | +75.0% | -23.6% | -10000.0% |
SYRS Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -3.5% | +22.8% | -30.0% | +3.5% | -73.0% | at low |
| 5 y | 5-year | -3.5% | +32.6% | -30.0% | +10.2% | -180.5% | at low |
| alltime | all time | -3.5% | +1025.9% | -30.0% | +576.4% | -5422.8% | at low |
Syros Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $5.66 M(+3.5%) | $23.27 M(-8.3%) |
| Jun 2024 | - | $5.46 M(-12.8%) | $25.38 M(-6.5%) |
| Mar 2024 | - | $6.27 M(+6.4%) | $27.14 M(-4.0%) |
| Dec 2023 | $28.28 M(-3.5%) | $5.89 M(-24.2%) | $28.28 M(-4.8%) |
| Sep 2023 | - | $7.76 M(+7.5%) | $29.72 M(-1.0%) |
| Jun 2023 | - | $7.22 M(-2.4%) | $30.04 M(+0.9%) |
| Mar 2023 | - | $7.41 M(+1.0%) | $29.75 M(+1.6%) |
| Dec 2022 | $29.30 M(+27.2%) | $7.33 M(-9.2%) | $29.30 M(+3.2%) |
| Sep 2022 | - | $8.08 M(+16.3%) | $28.40 M(+10.6%) |
| Jun 2022 | - | $6.95 M(-0.1%) | $25.67 M(+5.9%) |
| Mar 2022 | - | $6.95 M(+8.1%) | $24.25 M(+5.3%) |
| Dec 2021 | $23.04 M(+8.0%) | $6.43 M(+20.3%) | $23.04 M(+2.4%) |
| Sep 2021 | - | $5.35 M(-3.2%) | $22.50 M(+0.9%) |
| Jun 2021 | - | $5.52 M(-3.8%) | $22.30 M(+1.8%) |
| Mar 2021 | - | $5.74 M(-2.6%) | $21.91 M(+2.8%) |
| Dec 2020 | $21.32 M(-0.7%) | $5.89 M(+14.4%) | $21.32 M(-2.3%) |
| Sep 2020 | - | $5.15 M(+0.4%) | $21.83 M(+0.6%) |
| Jun 2020 | - | $5.13 M(-0.3%) | $21.70 M(-0.3%) |
| Mar 2020 | - | $5.15 M(-19.6%) | $21.76 M(+1.3%) |
| Dec 2019 | $21.48 M | $6.40 M(+27.6%) | $21.48 M(+10.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $5.02 M(-3.4%) | $19.45 M(+6.2%) |
| Jun 2019 | - | $5.20 M(+6.8%) | $18.31 M(+8.0%) |
| Mar 2019 | - | $4.87 M(+11.3%) | $16.95 M(+4.9%) |
| Dec 2018 | $16.16 M(+16.4%) | $4.37 M(+12.8%) | $16.16 M(+4.1%) |
| Sep 2018 | - | $3.88 M(+0.9%) | $15.53 M(+1.9%) |
| Jun 2018 | - | $3.84 M(-5.7%) | $15.25 M(+2.5%) |
| Mar 2018 | - | $4.08 M(+9.0%) | $14.88 M(+7.1%) |
| Dec 2017 | $13.89 M(+32.8%) | $3.74 M(+4.1%) | $13.89 M(+6.3%) |
| Sep 2017 | - | $3.59 M(+3.5%) | $13.07 M(+7.9%) |
| Jun 2017 | - | $3.47 M(+12.5%) | $12.11 M(+8.3%) |
| Mar 2017 | - | $3.09 M(+5.7%) | $11.18 M(+6.8%) |
| Dec 2016 | $10.46 M(+82.6%) | $2.92 M(+10.9%) | $10.46 M(+6.2%) |
| Sep 2016 | - | $2.63 M(+3.7%) | $9.86 M(+11.7%) |
| Jun 2016 | - | $2.54 M(+7.1%) | $8.82 M(+21.4%) |
| Mar 2016 | - | $2.37 M(+2.6%) | $7.26 M(+26.8%) |
| Dec 2015 | $5.73 M(+128.1%) | $2.31 M(+44.6%) | $5.73 M(+67.6%) |
| Sep 2015 | - | $1.60 M(+62.4%) | $3.42 M(+87.8%) |
| Jun 2015 | - | $984.00 K(+17.7%) | $1.82 M(+117.7%) |
| Mar 2015 | - | $836.00 K | $836.00 K |
| Dec 2014 | $2.51 M | - | - |
FAQ
- What is Syros Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals annual SGA year-on-year change?
- What is Syros Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals quarterly SGA year-on-year change?
- What is Syros Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals TTM SGA year-on-year change?
What is Syros Pharmaceuticals annual SGA?
The current annual SGA of SYRS is $28.28 M
What is the all time high annual SGA for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high annual SGA is $29.30 M
What is Syros Pharmaceuticals annual SGA year-on-year change?
Over the past year, SYRS annual SGA has changed by -$1.02 M (-3.47%)
What is Syros Pharmaceuticals quarterly SGA?
The current quarterly SGA of SYRS is $5.66 M
What is the all time high quarterly SGA for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high quarterly SGA is $8.08 M
What is Syros Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, SYRS quarterly SGA has changed by -$2.11 M (-27.16%)
What is Syros Pharmaceuticals TTM SGA?
The current TTM SGA of SYRS is -$2.96 B
What is the all time high TTM SGA for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high TTM SGA is -$53.51 M
What is Syros Pharmaceuticals TTM SGA year-on-year change?
Over the past year, SYRS TTM SGA has changed by -$2.99 B (-10043.15%)